We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inivata’s RaDaR Assay Detects Residual Cancer in Study
Inivata’s RaDaR Assay Detects Residual Cancer in Study
Inivata released data at the American Association for Cancer Research Annual Meeting this week demonstrating the potential of its RaDaR assay for the detection of minimal residual disease (MRD) in cancer and its recurrence.